Preliminary study of the effects of morphine treatment on opioid receptor gene expression in brain structures of the female rat

Neuroscience

Volumn 141, Issue 3, 2006, Pages 1225-1231

  Teodorov, E ^a   Modena, C C ^a   Sukikara, M H ^a   Felicio, L F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

gene expression; opioidergic stimulation; opioids; PAG; peptides

Indexed keywords

MORPHINE; OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CHILDBIRTH; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE; GENE EXPRESSION; HYPOTHALAMUS; LACTATION; MATERNAL BEHAVIOR; NERVE CELL PLASTICITY; NEUROENDOCRINOLOGY; NONHUMAN; OPRK1 GENE; OPRM1 GENE; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REWARD; RNA EXTRACTION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENE EXPRESSION; MORPHINE; NARCOTICS; RATS; RATS, WISTAR; RECEPTORS, OPIOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33746708730     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.04.071     Document Type: Article

References (45)

1. Aghajanian G.K. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 276 (1978) 186-188
2. Bausch S.B., Patterson T.A., Appleyard S.M., and Chavkin C. Immunocytochemical localization of delta opioid receptors in mouse brain. J Chem Neuroanat 8 (1995) 175-189
3. Bridges R.S., and Grimm C.T. Reversal of morphine disruption of maternal behavior by concurrent treatment with the opiate antagonist naloxone. Science 218 (1982) 166-168
4. Chen Y., Mestek A., Liu J., and Yu L. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J 295 (1993) 625-628
5. Di Chiara G., and North R.A. Neurobiology of opiate abuse. Trends Pharmacol Sci 13 (1992) 185-193
6. Elde R., Arvidsson U., Riedi M., Vulchanova L., Lee J.H., Dado R., Nakano A., Charkrabarti S., Zhang X., and Loh H.H. Distribution of neuropeptide receptors. New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann N Y Acad Sci 757 (1995) 390-404
7. Felicio L.F., Mann P.E., and Bridges R.S. Intracerebroventricular cholecystokinin infusions block beta-endorphin-induced disruption of maternal behavior. Pharmacol Biochem Behav 39 (1991) 201-204
8. Fowler C.J., and Fraser G.L. Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem Int 24 (1994) 401-426
9. Gintzler A.R. Endorphin-mediated increases in pain threshold during pregnancy. Science 210 (1980) 193-195
10. Johnson S.M., and Fleming W.W. Mechanisms of cellular adaptative sensitivity changes. applications to opioid tolerance and dependence. Pharmacol Rev 41 (1989) 435-488
11. Kieffer B.L., Befort K., Gaveriaux R.C., and Hirth C.G. The delta-opioid receptor. isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 89 (1992) 12048-12052
12. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides. receptors for opioid peptides. Cell Mol Neurobiol 15 (1995) 615-635
13. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol 66 (2002) 285-306
14. Kinsley C.H., and Bridges R.S. Parity-associated reductions in behavioral sensitivity to opiates. Biol Reprod 39 (1988) 270-278
15. Mansour A., Fox C.A., and Watson S.J. Opioid-receptor mRNA expression in the rat CNS. anatomical and functional implications. Trends Neurosci 18 (1995) 22-29
16. Mansour A., Watson S.J., and Akil H. Opioid receptors. past, present and future. Trends Neurosci 18 (1995) 69-70
17. Mansour A., Hoversten M.T., Taylor L.P., Watson S.J., and Akil H. The cloned mu, delta and kappa receptors and their endogenous ligands. evidence for two opioid peptide recognition cores. Brain Res 700 (1995) 89-98
18. Mansour A., Fox C.A., Burke S., Akil H., and Watson S.J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 8 (1995) 283-305
19. Minami M., Toya T., Katao Y., Maekawa K., Nakamura S., Onogi T., Kaneko S., and Satoh M. Cloning and expression of a cDNA for the rat kappa-opioid receptor. FEBS Lett (1993) 329-295
20. Minami M., and Satoh M. Molecular biology of the opioid receptors. structures, functions and distributions. Neurosci Res 23 (1995) 121-145
21. Miranda-Paiva C.M., and Felicio L.F. Differential role of cholecystokinin receptor subtypes in opioid modulation of ongoing maternal behavior. Pharmacol Biochem Behav 64 (1999) 165-169
22. Miranda-Paiva C.M., Yim A., Nasello A.G., and Felicio L.F. Morphine pretreatment increases opioid inhibitory effects on maternal behavior. Brain Res Bull 55 (2001) 501-505
23. Miranda-Paiva C.M., and Felicio L.F. Puerperal blockade of cholecystokinin (CCK1) receptors disrupts maternal behavior in lactating rats. J Mol Neurosci 18 (2002) 97-104
24. Miranda-Paiva C.M., Ribeiro-Barbosa E.R., Canteras N.S., and Felicio L.F. A role for the periaqueductal grey in opioidergic inhibition of maternal behavior. Eur J Neurosci 18 (2003) 667-674
25. Narita M., Funada M., and Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89 (2001) 1-15
26. Nasello A.G., Depiante R., Tannhauser M., and Izquierdo I. Effect of morphine on the RNA and ATP concentration of brain structures of the rat. Pharmacology 10 (1973) 56-59
27. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16 (1993) 1-18
28. Paterson S.J., Robson L.E., and Kosterlitz H.W. Molecular neuroscience. In: Udenfriend S., and Meienhofer J. (Eds). The peptides Vol. 6 (1994), Academic Press, Orlando 147-189
29. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, New York
30. Porreca F., and Burks T.F. Supraspinal opioid receptors in antinociception. In: Herz A. (Ed). Opioids II. Handbook of experimental pharmacology (1993), Springer-Verlag, Berlin 21-52
31. Quinones-Jenab V., Jenab S., Ogawa S., Inturrisi C., and Pfaff D.W. Estrogen regulation of mu-opioid receptor mRNA in the forebrain of female rats. Brain Res Mol Brain Res 47 (1997) 134-138
32. Rimanóczy A., Slamberová R., and Vathy I. Prenatal morphine exposure alters estrogen regulation of kappa receptors in the cortex and POA of adult female rats but has no effects on these receptors in adult male rats. Brain Res 894 (2001) 154-156
33. Rosenblatt J.S., Mayer A.D., and Giordano A.L. Hormonal basis during pregnancy for the onset of maternal behavior in the rat. Psychoneuroendocrinology 13 (1988) 29-46
34. Slamberová R., Rimanóczy A., Riley M.A., Schindler C.J., and Vathy I. Mu-opioid receptors in seizure-controlling brain structures are altered by prenatal morphine exposure and by male and female gonadal steroids in adult rats. Brain Res Bull 58 (2002) 391-400
35. Slamberová R., Rimanóczy A., Schindler C.J., and Vathy I. Cortical and striatal μ-opioid receptors are altered by gonadal hormone treatment but not by prenatal morphine exposure in adult male and female rats. Brain Res Bull 62 (2003) 47-53
36. Slamberová R., Rimanóczy A., Bar N., Schindler C.J., and Vathy I. Density of μ-opioid receptors in the hippocampus of adult male and female rats is altered by prenatal morphine exposure and gonadal hormone treatment. Hippocampus 13 (2003) 461-471
37. Slamberová R., Rimanóczy A., Cao D., Schindler C.J., and Vathy I. Alterations of prenatal morphine exposure in μ-opioid receptor density in hypothalamic nuclei associated with sexual behavior. Brain Res Bull 65 (2005) 479-485
38. Stevens K.E., Mickley G.A., and McDermott L.J. Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse. Pharmacol Biochem Behav 24 (1986) 1739-1747
39. Sukikara M.H., Mota-Ortiz S.R., Baldo M.V., Felicio L.F., and Canteras N.S. A role for the periaqueductal gray in switching adaptive behavioral responses. J Neurosci 26 (2006) 2583-2589
40. Uhl G.R., Childers S., and Pasternak G. An opiate-opioid gene family reunion. Trends Neurosci 17 (1994) 89-93
41. Vathy I., Slamberová R., Rimanóczy A., Riley M.A., and Bar N. Autoradiographic evidence that prenatal morphine exposure sex-dependently alters mu-opioid receptor densities in brain regions that are involved in the control of motivated, and reinforcing or rewarding behaviors and drugs of abuse. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 381-393
42. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors. Annu Rev Biochem 73 (2004) 953-990
43. Wise R.A. Neurobiology of addiction. Curr Opin Neurobiol 6 (1996) 243-251
44. Yim A.J., Miranda-Paiva C.M., Florio J.C., Oliveira C.A., Nasello A.G., and Felicio L.F. A comparative study of morphine treatment regimen prior to mating and during late pregnancy. Brain Res Bull 68 (2006) 384-391
45. Zagon T.S., and McLaughlin P.J. Maternal exposure to opioids and the developing nervous system. laboratory findings. In: Zagon I.S., and Slotkin T.A. (Eds). Maternal substance abuse and the developing nervous system (1992), Academic Press, San Diego, CA 241-282